Carvedilol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C24H26N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0K47UL67F2, chemically known as 2-propanol, 1-(9h-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-, (+-)- but generally known as carvedilol, which bears US NIH Compound Identifier 2585. Carvedilol most often comes in base and phosphate forms. European Medicines Agency schedules Carvedilol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06153MIG. The term CARVEDILOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). World Health Organization schedules carvedilol in its Anatomical Therapeutic Chemical (ATC) Classification. CARVEDILOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule carvedilol under HS 29339990 and SITC 51577. As of Q4 2014, CARVEDILOL remains the US FDA Preferred Term for this commodity. Carvedilol bears US NLM identifiers UMLS ID C0719509 and NCI Concept Code C28906. SMILES: O(C1C2C3C([NH]C2CCC1)CCCC3)CC(O)CNCCOC1C(OC)CCCC1.